When HPV was first linked to cancer: from a priest's observation to a vaccine
Last reviewed November 16, 2026. OwieClear editorial team. Waiting for clinician review. Not medical advice. Talk with your doctor about your own care.
The idea that a cancer could be caused by an infection was, for most of medical history, close to unthinkable. The HPV story is how that idea was proven, against considerable resistance.
It starts with a doctor counting who got cervical cancer and who didn't, almost two centuries ago.
Related pages: HPV infection · Cervical precancer or cancer
The bottom line
- Harald zur Hausen's group isolated HPV 16 in 1983 and HPV 18 in 1984, from cervical cancer tissue.
- He shared the 2008 Nobel Prize in Physiology or Medicine for the discovery.
- The first HPV vaccine was approved in 2006.
- Credit for the vaccine itself, which was disputed in court and involved several research groups.
The timeline
- 1. 1842 (Domenico Rigoni-Stern)
- 2. 1907 and 1933 (Giuseppe Ciuffo; later Richard Shope)
- 3. 1970s (Harald zur Hausen)
- 4. 1979 to 1984 (zur Hausen's group, including Lutz Gissmann, Ethel-Michele de Villiers, Mathias Durst and Michael Boshart)
- 5. 2006 to 2008 ()
A doctor notices who does and doesn't get cervical cancer
What happened
Rigoni-Stern analyzed death records and compared cervical cancer rates between groups of women.
What was found
- Married women and widows died of cervical cancer far more often than nuns.
- That pattern pointed toward something transmitted by sexual contact.
- His paper became famous as the first epidemiological hint of an infectious cause.
Why it matters
Long before viruses could be seen or studied, counting cases pointed in the right direction.
What's debated
- The groups differed in many other ways, and the finding was open to other interpretations at the time.
Read more
Next: 1907 and 1933
Warts are shown to be viral, first in people then in rabbits
What happened
Ciuffo transmitted warts using cell-free filtrate, meaning material with all cells removed.
What was found
- Because nothing but a filterable agent could have carried it, this established that warts are caused by a virus.
- In 1933 Richard Shope described a papillomavirus causing warty growths in cottontail rabbits, which could progress to cancer.
- The rabbit model became the main tool for studying papillomaviruses for decades.
Why it matters
By the 1930s there was an animal papillomavirus that caused cancer. The human link still took another 50 years.
What's debated
- Animal papillomaviruses differ enough from human ones that findings didn't always transfer.
Read more
- zur Hausen 2009Journal
Next: 1970s
zur Hausen bets against the consensus
What happened
At the time, herpes simplex virus type 2 was the accepted suspect for cervical cancer. zur Hausen's group looked for HSV-2 DNA in cervical cancer tissue and found none.
What was found
- Because genital warts were known to contain papillomavirus particles, he suspected a wart virus instead.
- He published the hypothesis in 1976 and spent years pursuing it.
- He reasoned that the viral DNA might be present in a non-productive state, detectable only by searching for the DNA itself.
- An important early clue was that different papillomaviruses existed, not one.
Why it matters
The key insight was methodological: look for viral DNA hiding in tumor cells rather than for whole virus particles.
What's debated
- The work was slow and went against the field's consensus for years.
Read more
Next: 1979 to 1984
HPV 6, then 11, then the two that mattered
What happened
The group cloned HPV DNA from genital warts and used each new type as a probe to find related ones.
What was found
- HPV 6 was cloned from genital warts in late 1979, then HPV 11 from a laryngeal papilloma.
- Neither was common in cervical cancer, which was initially disappointing, but using HPV 11 as a probe found a positive result in 1 of 24 cervical cancer samples.
- That led to the isolation of HPV 16 in 1983 and HPV 18 in 1984, the latter from cervical cancers and cancer cell lines including HeLa.
- HPV 16 was present in about half of cervical cancer samples, HPV 18 in around a fifth.
- The viral DNA was commonly found integrated into the tumor's chromosomes, showing the tumors grew from single infected cells.
Why it matters
This is the discovery that made everything after it possible: screening by HPV testing, and a vaccine aimed at specific types.
What's debated
- Acceptance took years, and the vaccine took two more decades.
Read more
- zur Hausen's own accountGovernment
Next: 2006 to 2008
A vaccine, then a Nobel Prize
What happened
Vaccines were built from empty shells of the virus's outer protein, which trigger antibodies without any viral DNA.
What was found
- The first HPV vaccine was approved in the United States in 2006.
- In 2008 zur Hausen received half of the Nobel Prize in Physiology or Medicine for discovering the human papillomaviruses that cause cervical cancer.
- A later 9-valent vaccine extended coverage to seven high-risk types plus the two main wart types.
- Countries with high vaccination coverage have since seen large falls in infection, genital warts and precancerous lesions.
Why it matters
From a count of death records in 1842 to a vaccine that prevents the cancer, in about 165 years.
What's debated
- Coverage remains uneven worldwide, and cervical cancer still kills hundreds of thousands of women a year, mostly where screening and vaccination are least available.
Read more
- Nobel Prize 2008Government
- OwieClear: Can a vaccine stop cancer? The HPV vaccine storyOwieClear